sellWeak
Vassiliki Economides sold $180 of GRTS
EVP, CHIEF FINANCIAL OFFICER at Gritstone bio, Inc.. 12,000 shares at an average of $0.02, traded Dec 18, 2024, filed Dec 20, 2024.
Warning score
22Value
$180
12,000 shares
Holdings after
250,437
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- 0Trade size$180 at market
- 0Share of holdings soldSold 4.6% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-029968, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2024 | SOpen-market sale Common Stock | -12,000 | $0.02 | $180 | 250,437 | Dec 20, 2024 |
Related signals
Other insiders at Gritstone bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Gritstone bio, Inc. | Andrew R Allen PRESIDENT AND CEO | $18k 24,263 shares | -2% | |
| 37Weak | Gritstone bio, Inc. | Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER | $10k 13,749 shares | -5% | |
| 30Weak | Gritstone bio, Inc. | Matthew Hawryluk EVP, CHIEF BUSINESS OFFICER | $6,929 9,259 shares | -3% | |
| 30Weak | Gritstone bio, Inc. | Karin Jooss SEE REMARKS | $10k 13,749 shares | -2% | |
| 35Weak | Gritstone bio, Inc. | Erin Jones EVP, CHIEF OPERATING OFFICER | $10k 13,749 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.